421.04
price up icon0.59%   2.46
pre-market  Pre-mercato:  420.99   -0.05   -0.01%
loading
Precedente Chiudi:
$418.58
Aprire:
$420.63
Volume 24 ore:
429.82K
Relative Volume:
0.56
Capitalizzazione di mercato:
$18.99B
Reddito:
$3.08B
Utile/perdita netta:
$1.24B
Rapporto P/E:
16.44
EPS:
25.6108
Flusso di cassa netto:
$1.07B
1 W Prestazione:
-2.69%
1M Prestazione:
-2.69%
6M Prestazione:
+44.50%
1 anno Prestazione:
+20.76%
Intervallo 1D:
Value
$411.92
$422.39
Intervallo di 1 settimana:
Value
$411.92
$432.20
Portata 52W:
Value
$266.98
$459.48

United Therapeutics Corp Stock (UTHR) Company Profile

Name
Nome
United Therapeutics Corp
Name
Telefono
(301) 608-9292
Name
Indirizzo
1000 SPRING ST, SILVER SPRING, MD
Name
Dipendente
1,305
Name
Cinguettio
Name
Prossima data di guadagno
2024-10-30
Name
Ultimi documenti SEC
Name
UTHR's Discussions on Twitter

Confronta UTHR con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
421.04 18.93B 3.08B 1.24B 1.07B 25.61
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
147.53 64.68B 9.39B 2.62B 2.22B 5.8121
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.17 44.25B 29.96B 957.25M 4.77B 0.2956
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.20 41.19B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
19.61 21.74B 16.70B -157.13M 1.19B -0.1446

United Therapeutics Corp Stock (UTHR) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-10-20 Iniziato Wells Fargo Underweight
2025-09-26 Iniziato RBC Capital Mkts Outperform
2025-06-02 Iniziato Cantor Fitzgerald Overweight
2025-04-25 Downgrade Wells Fargo Overweight → Equal Weight
2025-04-21 Aggiornamento BofA Securities Underperform → Neutral
2024-07-11 Downgrade Morgan Stanley Overweight → Equal-Weight
2024-02-12 Aggiornamento Goldman Sell → Neutral
2024-02-05 Iniziato Leerink Partners Outperform
2023-12-08 Iniziato Wells Fargo Overweight
2022-12-06 Iniziato UBS Buy
2022-12-05 Iniziato Goldman Sell
2022-10-11 Iniziato Morgan Stanley Overweight
2022-09-20 Reiterato BofA Securities Underperform
2022-09-19 Ripresa Wedbush Outperform
2022-02-11 Iniziato BTIG Research Neutral
2021-07-14 Aggiornamento Argus Hold → Buy
2021-04-26 Ripresa Credit Suisse Outperform
2021-02-01 Aggiornamento H.C. Wainwright Neutral → Buy
2020-09-14 Ripresa JP Morgan Overweight
2020-06-25 Reiterato H.C. Wainwright Neutral
2020-03-10 Aggiornamento Jefferies Hold → Buy
2020-02-27 Aggiornamento Cowen Market Perform → Outperform
2020-01-31 Aggiornamento JP Morgan Neutral → Overweight
2019-12-03 Iniziato BofA/Merrill Underperform
2019-08-01 Aggiornamento Jefferies Underperform → Hold
2019-08-01 Aggiornamento Ladenburg Thalmann Neutral → Buy
2019-07-01 Aggiornamento Credit Suisse Neutral → Outperform
2019-05-17 Aggiornamento UBS Sell → Neutral
2019-05-09 Aggiornamento Credit Suisse Underperform → Neutral
2018-10-12 Aggiornamento Standpoint Research Hold → Buy
2018-08-08 Downgrade Credit Suisse Neutral → Underperform
2018-04-03 Aggiornamento Credit Suisse Underperform → Neutral
2018-02-22 Reiterato Barclays Underweight
2018-01-18 Ripresa Credit Suisse Underperform
2017-12-27 Reiterato Wedbush Outperform
2017-04-27 Reiterato Wedbush Outperform
2017-03-30 Iniziato UBS Sell
2017-03-16 Iniziato Credit Suisse Underperform
Mostra tutto

United Therapeutics Corp Borsa (UTHR) Ultime notizie

pulisher
Oct 27, 2025

United Therapeutics’ Promising Study on Inhaled Treprostinil for Lung Disease - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

United Therapeutics’ Promising Phase 3 Study on Inhaled Treprostinil for Pulmonary Fibrosis - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

United Therapeutics’ AI-Driven Study: A Potential Game-Changer for Pulmonary Hypertension Diagnosis - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

United Therapeutics’ Xenokidney Study: A New Hope for ESRD Patients - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

United Therapeutics’ DeciPHer-ILD Study: A Closer Look at PH-ILD Patient Registry - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

United Therapeutics’ PHINDER Study: A Step Forward in Early Detection of Pulmonary Hypertension - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

United Therapeutics Advances Ralinepag Study for PAH Treatment - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

Will United Therapeutics Corporation stock benefit from upcoming earnings reports2025 Risk Factors & Reliable Breakout Forecasts - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

What margin trends mean for United Therapeutics Corporation stockMarket Growth Review & Consistent Profit Trading Strategies - newser.com

Oct 27, 2025
pulisher
Oct 26, 2025

Nepsis Liquidates $14 Million CyberArk Software (NASDAQ: CYBR) Position: Did the Stock Soar Too High, Too Fast? - The Motley Fool

Oct 26, 2025
pulisher
Oct 26, 2025

Published on: 2025-10-26 13:21:57 - newser.com

Oct 26, 2025
pulisher
Oct 26, 2025

Will United Therapeutics Corporation benefit from macro trendsMarket Weekly Review & Precise Swing Trade Alerts - newser.com

Oct 26, 2025
pulisher
Oct 25, 2025

How United Therapeutics Corporation (UTH) stock benefits from digital adoptionJuly 2025 Catalysts & Reliable Entry Point Trade Alerts - newser.com

Oct 25, 2025
pulisher
Oct 22, 2025

United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells 8,000 Shares - TradingView

Oct 22, 2025
pulisher
Oct 22, 2025

United Therapeutics (UTHR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance

Oct 22, 2025
pulisher
Oct 21, 2025

What data driven models say about United Therapeutics Corporation’s future2025 Sector Review & Fast Moving Stock Watchlists - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Risk adjusted return profile for United Therapeutics Corporation analyzedJuly 2025 Volume & Fast Gain Swing Trade Alerts - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

What makes United Therapeutics Corporation stock attractive to growth fundsTrade Risk Assessment & Precise Trade Entry Recommendations - newser.com

Oct 21, 2025
pulisher
Oct 20, 2025

United Therapeutics Executives Sell Shares - TradingView

Oct 20, 2025
pulisher
Oct 20, 2025

United Therapeutics EVP & General Counsel Sells 11,000 Shares - TradingView

Oct 20, 2025
pulisher
Oct 20, 2025

Why United Therapeutics Corporation (UTH) stock gets analyst attention2025 Buyback Activity & Reliable Momentum Entry Alerts - newser.com

Oct 20, 2025
pulisher
Oct 18, 2025

United Therapeutics Corporation (UTHR) Stock forecasts - Yahoo

Oct 18, 2025
pulisher
Oct 18, 2025

Will United Therapeutics Corporation (UTH) stock attract long term capital inflowsJuly 2025 Setups & Weekly High Potential Alerts - Trung tâm Dự báo KTTV quốc gia

Oct 18, 2025
pulisher
Oct 16, 2025

Jefferies Reiterates Buy Rating on United Therapeutics (UTHR) Amid Patent Case - Insider Monkey

Oct 16, 2025
pulisher
Oct 15, 2025

United Therapeutics CEO Martine A. Rothblatt Sells 8,000 Shares - TradingView

Oct 15, 2025
pulisher
Oct 13, 2025

PH-ILD hospitalization data on inhaled treprostinil — United Therapeutics at CHEST 2025 - Stock Titan

Oct 13, 2025
pulisher
Oct 13, 2025

Callan Family Office LLC Increases Stock Position in United Therapeutics Corporation $UTHR - MarketBeat

Oct 13, 2025
pulisher
Oct 12, 2025

United Therapeutics (FRA:UTH) Gross-Profit-to-Asset % : 35.18% (As of Jun. 2025) - GuruFocus

Oct 12, 2025
pulisher
Oct 12, 2025

UTHR (United Therapeutics) Cyclically Adjusted PB Ratio : 4.79 (As of Oct. 12, 2025) - GuruFocus

Oct 12, 2025
pulisher
Oct 12, 2025

Inspire Investing LLC Trims Stock Position in United Therapeutics Corporation $UTHR - MarketBeat

Oct 12, 2025
pulisher
Oct 12, 2025

UTHR (United Therapeutics) 5-Year RORE % : 17.31% (As of Jun. 2025) - GuruFocus

Oct 12, 2025
pulisher
Oct 12, 2025

UTHR (United Therapeutics) Revenue per Share : $63.53 (TTM As of Jun. 2025) - GuruFocus

Oct 12, 2025
pulisher
Oct 09, 2025

Martine Rothblatt Sells 4,000 Shares of United Therapeutics (NASDAQ:UTHR) Stock - MarketBeat

Oct 09, 2025
pulisher
Oct 09, 2025

United Therapeutics Corp. Hits New 52-Week High of $455.26 - Markets Mojo

Oct 09, 2025
pulisher
Oct 09, 2025

United Therapeutics Corp. Hits New 52-Week High of $459.48 - Markets Mojo

Oct 09, 2025
pulisher
Oct 08, 2025

United Therapeutics Corp. Hits New 52-Week High of $455.00 - Markets Mojo

Oct 08, 2025
pulisher
Oct 08, 2025

United Therapeutics (NASDAQ:UTHR) Sets New 52-Week HighHere's What Happened - MarketBeat

Oct 08, 2025
pulisher
Oct 07, 2025

Insider Selling: United Therapeutics (NASDAQ:UTHR) COO Sells 22,500 Shares of Stock - MarketBeat

Oct 07, 2025
pulisher
Oct 06, 2025

QRG Capital Management Inc. Raises Stock Position in United Therapeutics Corporation $UTHR - MarketBeat

Oct 06, 2025
pulisher
Oct 05, 2025

Is There Still an Opportunity in United Therapeutics After Its 25.8% Year to Date Surge? - simplywall.st

Oct 05, 2025
pulisher
Oct 04, 2025

Polaris Capital Management LLC Reduces Stock Position in United Therapeutics Corporation $UTHR - MarketBeat

Oct 04, 2025
pulisher
Oct 04, 2025

Hilltop National Bank Takes $341,000 Position in United Therapeutics Corporation $UTHR - MarketBeat

Oct 04, 2025
pulisher
Oct 04, 2025

What Catalysts Are Reshaping the Narrative for United Therapeutics This Year? - Yahoo Finance

Oct 04, 2025
pulisher
Oct 03, 2025

A Look at United Therapeutics (UTHR) Valuation as Tyvaso Shows Breakthrough Results in Late-Stage IPF Trial - simplywall.st

Oct 03, 2025
pulisher
Oct 03, 2025

How Positive TETON-2 Results for Tyvaso Have Changed United Therapeutics' (UTHR) Investment Story - simplywall.st

Oct 03, 2025
pulisher
Oct 03, 2025

News impact scoring models applied to United Therapeutics CorporationPortfolio Growth Summary & Weekly Top Gainers Alerts - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Robeco Institutional Asset Management B.V. Boosts Stake in United Therapeutics Corporation $UTHR - MarketBeat

Oct 03, 2025
pulisher
Oct 02, 2025

United Therapeutics stock hits all-time high at 442.02 USD - Investing.com

Oct 02, 2025
pulisher
Oct 02, 2025

United Therapeutics stock hits all-time high at 442.02 USD By Investing.com - Investing.com South Africa

Oct 02, 2025
pulisher
Oct 02, 2025

United Therapeutics rides Tyvaso optimism as IPF trial gains momentum - S&P Global

Oct 02, 2025
pulisher
Oct 02, 2025

TD Cowen maintains Buy rating on United Therapeutics stock, citing IPF opportunity - Investing.com

Oct 02, 2025

United Therapeutics Corp Azioni (UTHR) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

United Therapeutics Corp Azioni (UTHR) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
ROTHBLATT MARTINE A
Chairperson & CEO
Oct 23 '25
Option Exercise
120.26
4,000
481,040
4,130
ROTHBLATT MARTINE A
Chairperson & CEO
Oct 24 '25
Option Exercise
120.26
4,000
481,040
4,130
ROTHBLATT MARTINE A
Chairperson & CEO
Oct 24 '25
Sale
424.06
4,000
1,696,259
130
ROTHBLATT MARTINE A
Chairperson & CEO
Oct 23 '25
Sale
422.18
4,000
1,688,730
130
$19.61
price up icon 3.48%
$148.94
price up icon 3.43%
$10.42
price up icon 0.68%
drug_manufacturers_specialty_generic RDY
$14.47
price down icon 0.75%
$22.27
price up icon 1.00%
Capitalizzazione:     |  Volume (24 ore):